Drug Profile
Nebracetam
Alternative Names: Memolog; WEB 1881; WEB 1881 FULatest Information Update: 09 Jan 2001
Price :
$50
*
At a glance
- Originator Boehringer Ingelheim
- Class Antidepressants; Nootropics; Pyrrolidinones; Small molecules
- Mechanism of Action Muscarinic M1 receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Alzheimer's disease
Most Recent Events
- 09 Jan 2001 No-Development-Reported for Alzheimer's disease in Germany (PO)
- 09 Jan 2001 No-Development-Reported for Alzheimer's disease in Japan (PO)
- 30 Apr 1997 Phase-III clinical trials for Alzheimer's disease in Germany (PO)